Mitsubishi UFJ Asset Management Co. Ltd. Buys New Shares in Humana Inc. $HUM

Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Humana Inc. (NYSE:HUM) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 290,935 shares of the insurance provider’s stock, valued at approximately $115,565,000.

Several other institutional investors also recently modified their holdings of HUM. Bogart Wealth LLC lifted its position in shares of Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Montag A & Associates Inc. grew its holdings in shares of Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new stake in shares of Humana during the fourth quarter worth $27,000. Reflection Asset Management purchased a new stake in shares of Humana during the fourth quarter valued at $29,000. Finally, Larson Financial Group LLC lifted its holdings in shares of Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after purchasing an additional 81 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of analyst reports. Seaport Research Partners cut Humana to a “neutral” rating in a research note on Wednesday, May 20th. Zacks Research lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. UBS Group began coverage on shares of Humana in a report on Thursday, July 30th. They issued a “buy” rating for the company. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a research report on Thursday, July 30th. Finally, Cantor Fitzgerald upped their price target on shares of Humana from $264.00 to $300.00 and gave the company a “neutral” rating in a research report on Tuesday, July 7th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $395.22.

Humana Trading Down 0.6%

NYSE HUM opened at $382.13 on Wednesday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The firm’s fifty day simple moving average is $382.93 and its 200-day simple moving average is $278.32. The company has a market capitalization of $45.89 billion, a PE ratio of 36.15, a price-to-earnings-growth ratio of 2.23 and a beta of 0.72.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. During the same quarter last year, the firm earned $6.27 earnings per share. The business’s revenue for the quarter was up 26.2% on a year-over-year basis. As a group, sell-side analysts anticipate that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.